BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 27470401)

  • 1. LncRNA-MEG3 inhibits cell proliferation of endometrial carcinoma by repressing Notch signaling.
    Guo Q; Qian Z; Yan D; Li L; Huang L
    Biomed Pharmacother; 2016 Aug; 82():589-94. PubMed ID: 27470401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MEG3 long non-coding RNA prevents cell growth and metastasis of osteosarcoma.
    Zhang SZ; Cai L; Li B
    Bratisl Lek Listy; 2017; 118(10):632-636. PubMed ID: 29198132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LncRNA MEG3 inhibit endometrial carcinoma tumorigenesis and progression through PI3K pathway.
    Sun KX; Wu DD; Chen S; Zhao Y; Zong ZH
    Apoptosis; 2017 Dec; 22(12):1543-1552. PubMed ID: 29094270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Numb/Notch signaling pathway modulation enhances human pancreatic cancer cell radiosensitivity.
    Bi YL; Min M; Shen W; Liu Y
    Tumour Biol; 2016 Nov; 37(11):15145-15155. PubMed ID: 27677287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The mechanism study of miR-125b in occurrence and progression of multiple myeloma.
    Gao D; Xiao Z; Li HP; Han DH; Zhang YP
    Cancer Med; 2018 Jan; 7(1):134-145. PubMed ID: 29214735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LncRNA MALAT1 promotes epithelial-to-mesenchymal transition of esophageal cancer through Ezh2-Notch1 signaling pathway.
    Chen M; Xia Z; Chen C; Hu W; Yuan Y
    Anticancer Drugs; 2018 Sep; 29(8):767-773. PubMed ID: 29916899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LncRNA SNHG1 promotes cell proliferation in laryngeal cancer via Notch1 signaling pathway.
    Liu T; Zuo JJ; Li F; Xu YC; Zheng AY; Tao ZZ
    Eur Rev Med Pharmacol Sci; 2019 Aug; 23(15):6562-6569. PubMed ID: 31378897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of long non-coding RNA MEG3 suppresses breast cancer cell proliferation, invasion, and angiogenesis through AKT pathway.
    Zhang CY; Yu MS; Li X; Zhang Z; Han CR; Yan B
    Tumour Biol; 2017 Jun; 39(6):1010428317701311. PubMed ID: 28635399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LncRNA HCG11/miR-579-3p/MDM2 axis modulates malignant biological properties in pancreatic carcinoma via Notch/Hes1 signaling pathway.
    Xu J; Xu W; Yang X; Liu Z; Sun Q
    Aging (Albany NY); 2021 Jun; 13(12):16471-16484. PubMed ID: 34230221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ZIC2 upregulates lncRNA SNHG12 expression to promote endometrial cancer cell proliferation and migration by activating the Notch signaling pathway.
    Cai P; Li G; Wu M; Zhang B; Bai H
    Mol Med Rep; 2021 Sep; 24(3):. PubMed ID: 34278490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Long Non-Coding RNA (lncRNA) AGAP2-AS1 is Upregulated in Ovarian Carcinoma and Negatively Regulates lncRNA MEG3.
    Chen J; Peng X; Dai Y
    Med Sci Monit; 2019 Jun; 25():4699-4704. PubMed ID: 31233485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LncRNA FER1L4 suppresses cancer cell proliferation and cycle by regulating PTEN expression in endometrial carcinoma.
    Qiao Q; Li H
    Biochem Biophys Res Commun; 2016 Sep; 478(2):507-12. PubMed ID: 27381864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNMT1-mediated demethylation of lncRNA MEG3 promoter suppressed breast cancer progression by repressing Notch1 signaling pathway.
    Pan T; Ding H; Jin L; Zhang S; Wu D; Pan W; Dong M; Ma X; Chen Z
    Cell Cycle; 2022 Nov; 21(21):2323-2337. PubMed ID: 35822955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LncRNA MEG3 inhibits the progression of prostate cancer by facilitating H3K27 trimethylation of EN2 through binding to EZH2.
    Zhou Y; Yang H; Xia W; Cui L; Xu R; Lu H; Xue D; Tian Z; Ding T; Cao Y; Shi Q; He X
    J Biochem; 2020 Mar; 167(3):295-301. PubMed ID: 31790140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long noncoding RNA MEG3 inhibits breast cancer growth via upregulating endoplasmic reticulum stress and activating NF-κB and p53.
    Zhang Y; Wu J; Jing H; Huang G; Sun Z; Xu S
    J Cell Biochem; 2019 Apr; 120(4):6789-6797. PubMed ID: 30556250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-141 Inhibits Gastric Cancer Proliferation by Interacting with Long Noncoding RNA MEG3 and Down-Regulating E2F3 Expression.
    Zhou X; Ji G; Ke X; Gu H; Jin W; Zhang G
    Dig Dis Sci; 2015 Nov; 60(11):3271-82. PubMed ID: 26233544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FOXA1 promotes tumor cell proliferation through AR involving the Notch pathway in endometrial cancer.
    Qiu M; Bao W; Wang J; Yang T; He X; Liao Y; Wan X
    BMC Cancer; 2014 Feb; 14():78. PubMed ID: 24512546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LncRNA MEG3 inhibits proliferation and promotes apoptosis of osteosarcoma cells through regulating Notch signaling pathway.
    Chen L; Wang J; Li JW; Zhao XW; Tian LF
    Eur Rev Med Pharmacol Sci; 2020 Jan; 24(2):581-590. PubMed ID: 32016959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interference of Notch1 inhibits the growth of glioma cancer cells by inducing cell autophagy and down-regulation of Notch1-Hes-1 signaling pathway.
    Yao J; Zheng K; Li C; Liu H; Shan X
    Med Oncol; 2015 Jun; 32(6):610. PubMed ID: 25920606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of gamma-secretase activity impedes uterine serous carcinoma growth in a human xenograft model.
    Groeneweg JW; Hall TR; Zhang L; Kim M; Byron VF; Tambouret R; Sathayanrayanan S; Foster R; Rueda BR; Growdon WB
    Gynecol Oncol; 2014 Jun; 133(3):607-15. PubMed ID: 24667249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.